Clinical Trial Update: Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin's Lymphoma [Phase 4]

View source ↗

Summary

Phase 4 trial update on Zevalin followed by Rituxan maintenance in previously treated low-grade non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low-grade Non-hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Rituxan (rituximab)
• Zevalin (ibritumomab tiuxetan)

Snippet

Sponsor: Biogen | Conditions: Lymphoma, Non-Hodgkin, Lymphoma, Low-Grade | Phase 4 | Status: COMPLETED